Capital Empowers the Upgrade of Medical AI Industry Forum to Unveil the Future of Healthcare

In recent years, with the continuous growth of medical data and the rapid advancement of computing capabilities such as cloud computing and big data, the smart healthcare industry is entering a period of rapid development. Meanwhile, the State Council has timely issued a series of favorable policies, including the Guiding Opinions on Promoting and Regulating the Application and Development of Health and Medical Big Data and the Development Plan for New-Generation Artificial Intelligence, signaling that an innovative revolution in the medical field is poised to unfold!

Capital market enthusiasm for smart healthcare is growing day by day. Domestic IT giants such as Baidu, Tencent, and Alibaba are racing to enter the smart healthcare sector, with products like Baidu Health Cloud, Tencent WeChat Healthcare, and Alibaba’s “Future Hospital” emerging in rapid succession. Mergers and acquisitions within the industry are surging, driving the integration of medical resources, strategic layout across the smart healthcare industrial chain, and expansion of AI applications in healthcare scenarios.

Based on global startup practices, smart healthcare currently covers multiple sectors, including insights and risk management, medical research, medical imaging and diagnostics, lifestyle management and monitoring, mental health, nursing, emergency room and hospital management, drug discovery, virtual assistants, and wearable devices.

Amid a favorable environment characterized by policy support, strong interest from capital markets, advancements in big data and IoT technologies, and the continuous discovery of application scenarios, an increasing number of primary-care hospitals are actively participating as pioneers in AI-driven healthcare. However, what is the viable business model in the field of AI healthcare? Where is the path forward for smart healthcare? And how can stakeholders establish a solid foothold?

Currently, innovators are continually emerging across a series of niche sectors, including AI-powered healthcare big data, AI-driven new drug R&D, AI-assisted medical imaging diagnosis, AI-enabled cloud services, and AI-integrated pharmaceutical distribution. How can capital support these initiatives to help outstanding projects scale up, thereby promoting industry-wide upgrading, establishing a comprehensive commercial closed loop for medical AI, and creating unique business models and competitive advantages? What progress has been made in the application of AI-assisted diagnosis in the field of chronic disease management? What changes will be brought about by AI empowerment throughout the entire healthcare process? What opportunities and challenges will lie ahead in the new era of capsule robots?

The “Forum on Capital Empowering the Industrial Upgrade of Medical AI,” hosted by BOC Group Investment Co., Ltd., is scheduled to be held at the Jinjiang Hotel in Chengdu on October 28.This forum brings together financial institutions in the healthcare investment sector, innovative healthcare enterprises, and renowned medical experts. It will conduct professional and in-depth discussions on topics such as AI-assisted diagnosis, AI-enabled healthcare, development trends, commercial closed-loop models, and capital investment opportunities. By examining current hot issues in the smart healthcare industry from the perspectives of capital, enterprises, and medical practitioners, the forum aims to help you envision the future of healthcare!

No time for explanations—scan the QR code to register now!